Pharmafile Logo
Pharmafocus logo
Advanced Search

ipsen

Showing 15 posts of 33 posts found.

top_ten

Top Ten most popular articles on Pharmafile.com this week

March 2, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Alzheimer's, AstraZeneca, Botox, Celgene, EMA, FDA, Merck, Mylan, Pfizer, Roche, Takeda, ipsen, vaccines

We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …

News
david_meek_web

Ipsen: Becoming a “development powerhouse”

March 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Insider Interview, ipsen, pharma

Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …

Feature

NICE recommends thyroid cancer drug trio for NHS use

February 20, 2018
Manufacturing and Production, Sales and Marketing Bayer, Cancer, Cometriq, Eisai, Lenvima, NICE, Nexavar, ipsen, pharma, thyroid cancer

NICE has announced its decision to recommend that three separate treatments for thyroid cancer should be made available for use …

News
online

Ipsen promotes new CMO from within

January 31, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen has announced that Sotirios G. Stergiopoulos will become its newest Chief Medical Officer, performing the role alongside his current …

Appointment
cabometyx_tablets_60_mg_40_mg_20_mg

Ipsen ends P3 trial on liver cancer early due to strong data

January 18, 2018
Research and Development Cabometyx, Exelixis, biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen and Exelixis, partners in developing Cabometyx (cabozantinib), have revealed that they have cut short a Phase 3 trial into …

News

Dr Aidan Murphy becomes Ipsen’s new Executive VP, Technical Operations

January 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at …

Appointment
ian_w

Ipsen announces new Vice President of Corporate External Communications

September 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen

French biopharmaceutical group Ipsen has announced that Dr Ian Weatherhead has taken up the position of Vice President, Corporate External …

Appointment

Ipsen appoints new Executive Vice President

March 2, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ipsen

Ipsen has announced the appointment of Benoit Hennion as Executive Vice President and President of Primary Care. Hennion has worked …

Appointment

NICE provisionally rejects Ipsen’s kidney cancer drug Cabometyx

February 21, 2017
Manufacturing and Production, Sales and Marketing Cometriq, NICE, ipsen

NICE has announced draft guidance for Ipsen’s cancer drug Cabometyx (cabozantinib), revealing it does not recommend the drug for use on …

News
ipsen_small

Ipsen to acquire Sanofi assets in $88 million deal

February 13, 2017
Sales and Marketing Boehringer Ingelheim, Prontalgine, Sanofi, ipsen

Ipsen has announced that it is set to enter into a definitive agreement to acquire five consumer healthcare products from …

News
harout_semerjian

Ex-Novartis exec joins Ipsen as President, Head of Specialty Care

February 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen

Harout Semerjian has joined French pharma firm Ipsen as President, Head of Specialty Care International Region & Global Franchises, the …

Appointment
stergiopoulous

Ipsen names new Head of Global Medical Affairs

February 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen

French pharmaceutical firm Ipsen has announced its recruitment of Dr Sotirios Stergiopoulos as its Senior Vice President and Head of …

Appointment
handshake-1910702_960_720

Merrimack sells off drug for $1 billion and cuts workforce by 80%

January 9, 2017
Sales and Marketing Onivyde, ipsen, merrimack

Ipsen has announced the agreement to acquire oncology assets from Merrimack Pharmaceuticals, most notably the pancreatic cancer drug Onivyde, in …

News
peptimimesis

Ipsen and PeptiMimesis announce oncology research partnership

March 9, 2016
Research and Development INSERM, PeptiMimesis, ipsen, peptides

Specialist pharma company Ipsen is partnering with French start-up PeptiMimesis to develop and market of novel therapeutic peptides in oncology. …

News
ipsen_logo

Exelixis signs $200 million licensing deal for cancer drug

March 1, 2016
Research and Development, Sales and Marketing Cancer, Cometriq, Exelixis, ipsen

Exelixis has signed a licensing agreement with French biotech firm Ipsen for its cancer drug Cometriq (cabozantinib) for an upfront …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026